The CELPHAR-WUHRLIN brand, founded in 1971 (France), from 2466 sister brands and 17477 competing brands. CELPHAR-WUHRLIN is a brand of JOHNSON & JOHNSON, listed on the stock exchange of New York. CELPHAR-WUHRLIN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(CELPHAR-WUHRLIN)
over 5 years*
USD 159.07